Health
New Drug Developments Target Genetic Heart Risk Factor
By Editor • August 26, 2026 • 1 min read
Drugmakers are targeting Lp(a), a genetic cardiovascular risk factor, with new treatments in late-stage trials, including efforts from Novartis.
Read more